Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Joint statement on the use of flukicides in dairy cattle
'When prescribing, it is important to be aware of the withdrawal period requirements'

Document contains a summary of the various products available.

A joint statement on the use of flukicides in dairy cattle has been released by the National Office of Animal Health (NOAH) and the Veterinary Medicines Directorate (VMD).

Flukicides are anthelmintic veterinary medicines that are active against parasites from the trematode class. The most common parasite in this class is the liver fluke.

The statement reads: 'Vets, Suitably Qualified Persons (SQPs) and farmers are generally required to follow the instructions on the product labels; however, the prescribing decision rests with the vet, pharmacist or SQP.

'When prescribing, it is important to be aware of withdrawal period requirements specified on the labels and farmers should follow the advice given by the vet or the SQP.'

The statement also contains a summary of the various dairy cattle flukticides products authorised for sale in the UK.

Because some of the products place restrictions on the use of the product depending on the stage of pregnancy, users and prescribers are urged to consider this information carefully when treating animals. 

The full document can be read here.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.